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tive to qualify their estimates of time-related events, they find
no universally accepted term! Even the general name for the
analyses performed is not agreed on, in part because the
methodology is widely applicable: survival analysis, survival
modeling, survival data analysis, actuarial analysis, life table,
life-history analysis, life data analysis, life-testing, failure-
time data, event-history analysis, and censored data analysis (I
may have missed some). We see survival analysis in the nar-
row context of death and other time-related morbid events in
cardiothoracic surgery; however, historically, it has roots in
other disciplines that continue to contribute to its develop-
ment, including demography, annuities and insurance, and
life-history of machinery in industry. These are further gener-
alized to competing risks, multiple decrement, Markov
process, and other names, not to mention the host of names
associated with biomathematical models! The terms have
come from different, often independent, historical roots, but
they all relate to the general mathematical and statistical the-
ory of counting processes (martingales).
History. The word actuarial comes from the Latin actuar-
ius, secretary of accounts. The most notable actuarius was the
Praetorian Prefect Domitius Ulpianus, who produced a table of
annuity values early in the 3rd century AD.1 This table contin-
ued to be used in Europe through the 18th century and even
into the early 19th. With the emergence of both solid popula-
tion data and the science of probability, modern so-called life
tables were produced by Edmund Halley2 (of comet fame) in
1693. He was motivated, as was the actuarius Ulpianus, by
economics as related to human survival (annuities, life insur-
ance). Workers in this combined area of demography and eco-
nomics came to be called actuaries in the late 18th century.
Importantly for this discussion, the methodology of the actuary
varied widely. In the 19th century the actuary of the Alliance
of London, Benjamin Gompertz,3 developed physiologically
based mathematical models of the dynamic human processes
of birth and death to characterize survival. This model-based,
completely parametric (equations with constants estimated
from data) methodology was substantially different from the
simple empiric counting methodology of Halley.
In the 300 years since Halley, a multitude of methods has
been developed, and often reinvented, in actuarial science,
demography, statistics, industry, and medical science. They all
have the common goal of estimating the distribution of the
intervals between a designated time zero and the occurrence of
an event. In modern times, they also imply a suite of method-
ology applicable to incomplete data. That is, they permit esti-
mates of at least portions of the distribution to be made when,
for many subjects, the time of the event’s occurrence is only
known to be beyond the last time of observation (so-called
right censoring, one of several types of incomplete data).
Estimators versus adjectives. With this background I
come to the crux of Dr Wormuth’s concerns. When authors
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Actuarial and Kaplan-Meier survival analysis:
There is a difference
To the Editor:
While attending the Seventy-ninth Annual Meeting of The
American Association for Thoracic Surgery in New Orleans,
I was dismayed to see the almost universal misuse of the term
“actuarial survival.”
There are two general types of analysis for survival infor-
mation: actuarial and Kaplan-Meier. An actuarial analysis
should be performed when the actual date of a survival event
is unknown. The known information is that the event
occurred between time tn and time tn+1. Actuarial analysis is
carried out at specific time intervals (6 months, 1 year), and
the resulting graph will step only at those intervals. As the
actual failure time is only approximated by the end point, the
convention is to attribute a survival time of the fully com-
pleted intervals plus half the time of the interval during which
the event occurred. Examples of events needing actuarial
analysis include population-based death rates and disease-
free survival.
Kaplan-Meier analysis is used when the actual date of the
end point is known. End points not reached are treated as cen-
sored at the date of last follow-up for the analysis. Kaplan-
Meier analysis is undertaken at each survival event, death, or
censoring, and the graphs will step at each failure time and
may or may not be drawn to show the location of censored
observations. Examples of an appropriate event for Kaplan-
Meier analysis would be postoperative survival when the date
of deaths is known.
Most of the misuse of the term “actuarial survival” came
during presentation of data with well-known end points and
graphs that clearly reflected a Kaplan-Meier analysis. To mis-
label the precise survival estimates with the term “actuarial sur-
vival” suggests a limited understanding of survival analysis.
David W. Wormuth, MD, MPH






Reply to the Editor:
We are indebted to Dr Wormuth for drawing attention to
inaccurate terminology related to so-called survival analysis
that has crept into our Association’s annual meeting (and into
submitted manuscripts). Communication is the essence of
such meetings and of the Journal; yet communication con-
troversies continue even within cardiothoracic surgery in the
area of medical terminology. These pale, however, in com-
parison with those in the arena of survival analysis. When
presenters and authors deem it necessary to select an adjec-
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speak or write of actuarial survival, are they communicating
inaccurately the method or formula applied to data to obtain
survival estimates (the estimator), or are they simply using a
historically rooted generic adjective to identify that the esti-
mates are based on time-to-event data? My personal opinion
is that they are using an adjective to identify a general type of
data and its analysis rather than identifying a specific estima-
tor. Dr Wormuth believes that they are specifying the estima-
tor. Regardless, we routinely advise authors against use of
any adjective in front of the word “survival” (and against the
use of the further qualifier “rate”) because it is unnecessary.
They can simply state “Survival was….” The “Methods” sec-
tion of the manuscript should identify the estimator used to
obtain the survival estimates.
The Kaplan-Meier estimator. As Dr Wormuth states,
these days the most commonly used estimator for survival
and other time-related morbid events in medicine is the prod-
uct-limit estimator described by Kaplan and Meier4 and
called the Kaplan-Meier estimator. It represents the unlikely
synthesis of its two authors, one working with life-times of
vacuum tubes in the repeaters in telephone cables buried in
the ocean and the other working with medical follow-up stud-
ies. They were forced to generate a joint paper by the editor
of the Journal of the American Statistical Association, who
recognized that their individual submissions on the subject of
“failures” in the face of incomplete information were really
about the same subject.
Its advantage is a firm basis in probability and statistical
theory, widespread availability in commercial statistical com-
puter programs, and its visual appeal of presenting the most
atomic details of the distribution of times to events. We
encourage authors to use fully the estimates obtained by
application of this methodology in their graphs, for they pro-
vide more visual information than does unnecessary coarse
collapsing of the estimates into interval values (as would be
the product of the so-called actuarial estimator).
I would also quibble with the statement that “Kaplan-Meier
analysis is undertaken at each survival event, death, or cen-
soring.” In fact, the Kaplan-Meier estimator provides survival
estimates only at uncensored times (death) and not at cen-
sored times. Chin Long Chiang5 described a method that
accounts explicitly for the times of censoring, but for some
reason this more complicated method (requiring more than
counting) has not seen widespread implementation.
Finally, whether or not to connect Kaplan-Meier survival
estimates at all, to use a zero order interpolation (straight line)
as suggested by Dr Wormuth, or first-order or higher interpo-
lation (linear interpolation, spline interpolation) is not a set-
tled issue. Dr Yang-Ming Zhu in my group demonstrated that
both maximum entropy estimation and minimum norm esti-
mation favor at least some form of interpolation greater than
zero (step function) when using a nonparametric estimator
such as that of Kaplan and Meier.
The actuarial estimator. What seems generally agreed on
is that, in contrast to the Kaplan-Meier estimator, the actuar-
ial estimator generates survivorship (freedom from events)
estimates within time intervals, rather than at the time of each
event. However, the limit as the interval approaches zero is
the Kaplan-Meier estimator, as was described by Böhmer in
1912, long before the seminal paper by Edward Kaplan and
Paul Meier.
If I may be allowed to correct Dr Wormuth, the actuarial
estimator was, and is, often used in settings in which the
exact times of the events are known. For large populations,
grouping of times to death was convenient and saved compu-
tational time. Certainly the introduction of the actuarial esti-
mator to the medical mainstream by Berkson and Gage6 at
the Mayo Clinic was not motivated by having interval data,
but by not having readily available a better method! They
called the method the actuarial method because they had
obtained it from the 1922 writings of Murphy and Papps for
the Actuarial Society of America. I agree with Dr Wormuth
that, in most medical settings today, this interval method is
considered obsolete and more exact methods (such as the
Kaplan-Meier or Nelson-Aalen7 estimators) should be used.
Further, the word actuarial carries with it the historical con-
notation of economic inferences from the survival data, which
is generally not the case in medical follow-up reporting.
Today, the exact time of an event may not be known, only
that it occurred after some point in time and before a later
time point. This is known as interval-censored data. All mod-
ern life-table methods (for lack of a generic term for them),
including the method of Kaplan and Meier, can be modified
to accommodate a mixture of data with exact times of events
known and interval-censored data. Parametric methods allow
mixtures of data representing additional censoring types.8
Summary. Accuracy and clarity in communication are
important. However, this lengthy response to the issues raised
by Dr Wormuth indicates that communication within the sub-
ject of so-called survival analysis is not simple! There is lack
of an accepted generic adjective for analyses of time-related
events. There is historical baggage that suggests that in most
medical contexts “actuarial” has implications that are not
intended, although its introduction by Berkson at the Mayo
Clinic is compelling. One must distinguish between the type
of data at hand, the estimator applied to that data, and the esti-
mates thereby generated.
I dare say, in all these regards and including Dr Wormuth
and me, that we all have a “limited understanding of survival
analysis” (for lack of a better phrase with which to character-
ize it!).
Eugene H. Blackstone, MD
Associate Editor
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Cardioplegic solutions: Unproved herbal approach
versus tested scientific study
To the Editor:
The two criteria for cardiac surgical success are a techni-
cally adequate procedure and safe myocardial protection.
Experienced surgeons can readily introduce satisfactory tech-
nical changes that visibly work. For example, a coronary
anastomosis can be made with interrupted or running sutures,
by passing a needle either from the outside to inside, or inside
to outside, and either one surgeon doing all, or two surgeons,
each doing half, to maintain an ongoing forehand direct
suturing method. The barometer is that the anastomosis is
hemostatic, is patent, and remains open at follow-up exami-
nation. This end point is clear and documentable.
These specific limitations with cardioplegia may not be
clear in the operating room without this knowledge. For
example, an untested solution may produce a minor decrease
in protection, resulting in raised left ventricular end-diastolic
pressure (or left atrial pressure increases from 8 mm Hg to 16
mm Hg) with normal cardiac output in normal hearts. This
depression of the Starling function curve is not clear from
baseline resting measurements. However, cardiac output may
not increase sufficiently during anemia or fever. Of course,
these changes can occur also with tested solutions with any
form of myocardial protection, especially in damaged hearts.
Recognition of changes by a solution alone allows more
proper selection of crystalloid or blood cardioplegic con-
stituents.
The surgeon is not qualified to make arbitrary changes in
solutions to meet a whim. Suspicion of a useful change is
only a reason for pharmacologic testing. This was stated
clearly by Claude Bernard: “Clinical anecdotes should be the
seeds of subsequent investigative studies, and not the basis of
future decision making.”
The calcium concentration (Ca++) is lowered in the cardio-
plegic solution and reperfusate, because intracellular Ca++
accumulation follows ischemic and reperfusion injury.
However, Ca++ is not lowered too severely (<50 m m) to avoid
sarcolemmal damage that is caused by the calcium paradox.
This deleterious change was seen at the outset of clinical
cardioplegia with the Melrose solution in 1955. Careful
experimental testing (as described above) was not done. We
now know that Ca++ was lowered severely when citrate-phos-
phatedextrose (CPD) solution (which chelates calcium) was
added in high concentrations. Cardioplegia was initially
abandoned and then subsequently restored when
Bretschneider in 1964 and Gay and Ebert in 1971 imple-
mented experimental studies and showed clear benefits.
Today, our current blood cardioplegic solution uses safer
potassium and citrate components than were used in the orig-
inal Melrose solution. The quantity of blood/cardioplegia
mixture is recorded, and Ca++ is lowered to 0.5 to 0.6 m mol/L
with a 4:1 mixture and more severely, to 0.2 to 0.3 m mol/L, in
solutions for energy-depleted hearts or those with acute
myocardial infarction.
Similar testing with crystalloid Bretschneider solution or St
Thomas’ Hospital solution exposed the potential advantages
and disadvantages of these approaches. Consequently, the lit-
erature contains comparisons that allow surgeons to make
more knowledgeable selections of a desired blood or crystal-
loid solution.
I will relate specific issues with blood cardioplegia to show
that inaccurate choices can be problematic. Several years ago,
in children, we saw immediately after aortic unclamping,
transient atrioventricular dissociation or ventricular fibrilla-
tion. Normal rhythm was readily restored by pacing or defib-
rillation. The spontaneous beating empty state seen in adults
was not routine. We found that our hemodilution primes
diluted Ca++ to 0.6 to 0.8 m m in the blood component of our
cardioplegic solution. This iatrogenic hypocalcemia devel-
oped after extracorporeal circulation was begun and before
the cardioplegic mixture was made. Clearly a further lower-
ing of Ca++ occurred with any cardioplegic solution contain-
ing a fixed CPD concentration.
The lowering depended on the pump prime, with its known
content of Ringer’s lactate or electrolyte solution (Plasma-
Lyte). A supplemental plasma component will lower Ca++
further. We worked out the formulation of the amount of cal-
cium to be added to the crystalloid or crystalloid/plasma
pump prime to restore Ca++ to normal limits. These transient
arrhythmias were avoided by restoring normal Ca++ in the
pump prime.1
A more serious problem occurred at another institution.
The surgeon did not dilute our 4:1 cardioplegic solution, but
administered the entire cardioplegic component (containing
high potassium and CPD) directly into the heart. A problem
similar to that with the Melrose solution occurred, and a
patient died. I2 reported this hazard in a letter partially titled,
“Cardioplegic Solutions Are Not Equal.”
St Thomas’ Hospital solution (ie, a crystalloid solution)
was described in that report to show that this solution can be
delivered directly into the heart without blood. Our blood car-
dioplegic components were also presented to show that the
crystalloid components of blood cardioplegia would differ
depending on the ratio of 8:1, 4:1, 1:1, or other values.
Clearly, a reverse problem occurs by mixing crystalloid St
Thomas’ Hospital solution with blood, unless the electrolyte
concentrations are increased.
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